Celestica (NYSE:CLS) Stock Price Down 5.8% – Time to Sell?

Celestica, Inc. (NYSE:CLSGet Free Report) (TSE:CLS) traded down 5.8% on Friday . The stock traded as low as $298.53 and last traded at $298.87. Approximately 1,548,723 shares traded hands during trading, a decline of 37% from the average session volume of 2,442,090 shares. The stock had previously closed at $317.38.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CLS. JPMorgan Chase & Co. upped their target price on shares of Celestica from $445.00 to $485.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Rothschild & Co Redburn initiated coverage on shares of Celestica in a research report on Friday, May 1st. They issued a “buy” rating and a $460.00 price target for the company. Zacks Research upgraded shares of Celestica from a “hold” rating to a “strong-buy” rating in a research note on Friday, June 26th. Barclays dropped their price objective on Celestica from $430.00 to $406.00 and set an “overweight” rating on the stock in a report on Friday, August 7th. Finally, Weiss Ratings cut Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $439.81.

Get Our Latest Stock Report on Celestica

Celestica Trading Down 5.8%

The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The business’s 50 day simple moving average is $334.90 and its 200 day simple moving average is $335.87. The company has a market capitalization of $34.36 billion, a price-to-earnings ratio of 31.07 and a beta of 2.06.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last issued its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The firm had revenue of $4.68 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same quarter in the previous year, the firm posted $1.39 EPS. The firm’s revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Research analysts anticipate that Celestica, Inc. will post 10.42 EPS for the current year.

Insider Buying and Selling at Celestica

In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the transaction, the chief financial officer owned 82,444 shares in the company, valued at approximately $32,948,744.60. This represents a 17.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert Mionis sold 98,453 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total transaction of $36,328,172.47. The SEC filing for this sale provides additional information. Insiders sold a total of 356,553 shares of company stock worth $135,238,444 over the last three months. 1.10% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Celestica

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Corient Private Wealth LP increased its holdings in shares of Celestica by 30.8% in the 2nd quarter. Corient Private Wealth LP now owns 12,654 shares of the technology company’s stock valued at $4,616,000 after purchasing an additional 2,981 shares in the last quarter. Amundi grew its position in Celestica by 49.5% during the second quarter. Amundi now owns 319,304 shares of the technology company’s stock worth $116,501,000 after buying an additional 105,752 shares during the period. HighTower Advisors LLC grew its position in Celestica by 10.7% during the second quarter. HighTower Advisors LLC now owns 18,138 shares of the technology company’s stock worth $6,616,000 after buying an additional 1,747 shares during the period. Washington Trust Advisors Inc. purchased a new position in Celestica in the second quarter valued at about $28,000. Finally, Readystate Asset Management LP acquired a new stake in shares of Celestica during the 2nd quarter valued at approximately $1,996,000. Institutional investors and hedge funds own 67.38% of the company’s stock.

About Celestica

(Get Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Recommended Stories

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.